ReShape Lifesciences Inc.

0.00 (+0.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.27M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.62 Million
Adjusted EPS-$0.36
See more estimates
10-Day MA$0.35
50-Day MA$0.44
200-Day MA$0.95
See more pivots

ReShape Lifesciences Inc. Stock, NASDAQ:RSLS

1001 Calle Amanecer, San Clemente, California 92673
United States of America
Phone: +1.949.429.6680
Number of Employees: 47


ReShape Lifesciences, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShapeCare and Diabetes Bloc-Stim Neuromodulation Device. The company was founded in December 2002 and is headquartered in San Clemente, CA.